Advantage Trust Co XBI — SPDR S&P Biotech ETF

Ownership history in Advantage Trust Co  ·  10 quarters on record

AI Ownership Summary

Advantage Trust Co reported SPDR S&P Biotech ETF (XBI) in 10 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.45% in 2023 Q4. The latest visible filing shows XBI at 0.21% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this XBI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Advantage Trust Co's position in SPDR S&P Biotech ETF, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

XBI was reported at 0.21% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.45% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

XBI stock page Advantage Trust Co fund profile Advantage Trust Co full holdings
How Advantage Trust Co held XBI — position size vs. price
% of Fund (quarterly)    XBI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 3,645 — 0% 0.21% $466K 2026-05-05 $133.79
2025 Q4 REDUCED 14.1% +4.8% ❌ 3,645 -600 -14.1% 0.20% $444K 2026-01-29 $126.74
2025 Q3 UNCHANGED — — — 4,245 — 0% 0.19% $425K 2025-11-03 $109.50
2025 Q2 ADDED — — — 4,245 +500 +13.4% 0.17% $352K 2025-07-30 $85.93
2025 Q1 REDUCED 19.4% +2.3% ❌ 3,745 -900 -19.4% 0.18% $304K 2025-05-07 $77.07
2024 Q4 REDUCED 20.5% -9.9% ✅ 4,645 -1,200 -20.5% 0.25% $418K 2025-02-03 $91.08
2024 Q3 REDUCED 9.3% -9.0% ✅ 5,845 -600 -9.3% 0.39% $577K 2024-11-04 $98.85
2024 Q2 UNCHANGED — — — 6,445 — 0% 0.43% $598K 2024-08-09 $95.17
2024 Q1 UNCHANGED — — — 6,445 — 0% 0.45% $612K 2024-05-07 $89.97
2023 Q4 INITIATED — — — 6,445 — — 0.45% $575K 2024-02-07 $87.62

🏢 Other funds also holding XBI

As of 2026 Q1 — sorted by position size

PSP Research LLC 25.75% Sivik Global Healthcare LLC 3Y 7Y 14.55% Lake Hills Wealth Management, LLC 3Y 6.57% MARVIN & PALMER ASSOCIATES INC 3Y 7Y 4.61% Main Street Research LLC 3Y 7Y 4.22% Madrona Financial Services, LLC 3Y 7Y 3.69% Yelin Lapidot Holdings Management Ltd. 2.78% Investure, LLC 3Y 7Y 2.58% Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 3Y 2.58% Edge Wealth Management LLC 3Y 7Y 2.43%

FAQ About Advantage Trust Co and XBI

These are the practical questions this page is built to answer before you even open the full history table.

How long has Advantage Trust Co reported owning XBI?

Advantage Trust Co reported XBI across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported XBI position in Advantage Trust Co's portfolio?

The largest reported portfolio weight for XBI was 0.45% in 2023 Q4.

What is the latest reported XBI position on this page?

The most recent filing on this page is 2026 Q1, when Advantage Trust Co reported 3,645 shares, equal to 0.21% of portfolio, with an estimated market value of $466K.

What does the chart on this XBI ownership page compare?

The chart compares Advantage Trust Co's quarterly XBI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Advantage Trust Co time their XBI position?

Based on 13F filing dates vs. subsequent XBI price moves, Advantage Trust Co correctly timed 4 out of 6 reported position changes (67%). The annualised alpha on XBI relative to SPY over the holding period was +3.8%.

← Back to Advantage Trust Co Holdings